Weight Loss Predictor Project your weight loss journey based on clinical trial data
Continuous glucose monitoring (CGM) systems, increasingly available through the NHS for eligible patients, provide real-time glucose data and can alert users to falling glucose levels before symptoms develop
Katie Queen, who specializes in treating children with obesity, urged lawmakers to consider expanding qualifications for receiving the obesity medication to children
Wegovy received NICE approval in 2023 for weight management in adults with a BMI 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) with at least one weight-related comorbidity
In 2014, the FDA approved semaglutide (ozempic) for type 2 diabetes